Introduction {#s1}
============

Aneuploidy, an abnormal number of chromosomes, is a leading cause of mis-carriage and birth defects in humans ([@bib38]). In the vast majority of cases, this is due to errors occurring in the oocyte ([@bib38]). However, aneuploidy can also arise in somatic cells, and a number of studies have reported age-dependent increases in aneuploidy in human peripheral blood lymphocytes ([@bib44]; [@bib9]; [@bib34]). Moreover, aneuploidy was recognized as a common feature of cancer cells already a century ago ([@bib7], [@bib8]), and a causal role of aneuploidy in carcinogenesis is currently largely acknowledged (reviewed in \[[@bib46]; [@bib39]\]). In addition to being aneuploid, cancer cells typically display high rates of chromosome mis-segregation, a phenomenon termed *c*hromosomal *in*stability (CIN) ([@bib33]; [@bib3]). The observation that even mosaic aneuploidy can cause severe physical and cognitive developmental defects ([@bib5]) indicates that aneuploidy has pleiotropic deleterious effects. This idea is further supported by a number of experimental observations: first, knocking down spindle assembly checkpoint genes, which results in high rates chromosome mis-segregation and high levels of aneuploidy, invariably causes embryonic lethality in mouse models ([@bib20]). Second, aneuploid yeast strains were shown to exhibit defects in cell cycle progression and metabolism ([@bib67]). Third, MEFs derived from mice carrying specific trisomies were found to display cell proliferation defects and metabolic alterations ([@bib74]). Finally, genes involved in stress response were shown to be upregulated in aneuploid yeast and human cells ([@bib59]; [@bib62]). But in the context of cancer, aneuploidy and CIN strongly correlate with drug resistance ([@bib32]) and poor patient prognosis ([@bib4]; [@bib10]; [@bib73]; [@bib57]), indicating that aneuploidy and CIN may confer a proliferative advantage to cancer cells. In support of this idea, certain aneuploidies were found to confer drug resistance in aneuploid *Saccharomyces cerevisiae* ([@bib47]) and *Candida albicans* ([@bib55], [@bib56]). These studies suggest that aneuploidy may confer adaptability by inducing chromosome-specific phenotypic changes, despite general negative effects on cell physiology. However, this problem remains to be investigated in human cells.

Recent work in aneuploid budding yeast also showed that aneuploidy is sufficient to cause CIN ([@bib58]; [@bib77]), but whether this is true in human cells is still a matter of debate ([@bib18]; [@bib29]; [@bib70], [@bib71]). In fact, this question has been difficult to address in cancer cells due to the complexity of cancer karyotypes ([@bib25]; [@bib36]), and previous studies in human cancer and non-cancer cells have reached discrepant conclusions ([@bib33]; [@bib17]; [@bib37]; [@bib72]). To determine the effect of aneuploidy on chromosome segregation and cell division in human cells, we utilized a number of diploid human cell types and trisomic counterparts, including: colorectal cancer cell line DLD1 (2n = 46) and trisomic counterparts carrying extra copies of chromosomes 7 or 13 (DLD1+7 and DLD1+13, respectively); diploid amniotic fibroblasts (AF) and amniotic fibroblasts with trisomy 13 (AF+13). These different cell types constitute a good model for our study for two main reasons: first, their karyotypes are aneuploid, but not as complex as typically found in tumors and cancer cell lines; second, they represent different cellular models (transformed and untransformed) of aneuploidy.

Results {#s2}
=======

DLD1+7 and DLD1+13 cell lines were previously generated by micro-cell mediated chromosome transfer ([@bib69]), whereas AF and AF+13 cells (three cases each; see [Table 1](#tbl1){ref-type="table"}) were collected upon amniocentesis. The presence of the additional chromosome was confirmed by fluorescence in situ hybridization (FISH) with locus-specific probes ([Figure 1A--B](#fig1){ref-type="fig"}). Analysis of DLD1+7 cells previously showed that a large fraction (87%) of the population was trisomic ([@bib69]). However, the DLD1+13 cell population was shown to rapidly accumulate disomic (by loss of one copy of chromosome 13) and tetraploid cell populations ([@bib69]). Thus, for this study we sub-cloned DLD1+13 cells in order to select a more homogenous cell population. When we analyzed the clone selected for this study at early passages (P. 3--4) by chromosome 13 painting, we found that 83.5% of the cells in the population carried the trisomy 13 ([Figure 1C](#fig1){ref-type="fig"}). Similarly, analysis of AF+13 interphase nuclei (passage 1--2) FISH-stained with probes specific for chromosomes 13 and 21 showed that the cell populations used in this study were highly homogenous (88.1 ± 6.5%) for the trisomic karyotype ([Figure 1C](#fig1){ref-type="fig"}). Furthermore, we performed array comparative genomic hybridization (aCGH) of all three DLD1 cell lines ([Figure 1---figure supplement 1A,B,E](#fig1s1){ref-type="fig"}). In all DLD1 cell lines, we found amplification of regions on the p arm of chromosomes 2 and 11 and a deletion of a region on the p arm of chromosome 6, which are known to be recurrently found in DLD1 cells. In addition to these common copy number variations (CNVs), the DLD1+7 cell line (analyzed at passage 4) carried a partial trisomy 7 including most of the q arm ([Figure 1---figure supplement 1B--C](#fig1s1){ref-type="fig"}). FISH staining with a probe specific to the centromere of chromosome 7 confirmed that the extra chromosome included a centromere ([Figure 1---figure supplement 1D](#fig1s1){ref-type="fig"}). aCGH of DLD1+13 cells (at passage 11) showed that in addition to the CNVs identified in all three DLD1 cell lines, there was an extra copy of the entire chromosome 13 ([Figure 1---figure supplement 1E--F](#fig1s1){ref-type="fig"}). The experiments described hereafter were performed at passage number 7--25 for DLD1+7 cells and 13--25 for DLD1+13 cells to limit evolution of the karyotypes and passage number 1--3 for amniocytes, whose proliferation was limited to few passages.10.7554/eLife.05068.003Table 1.Euploid and trisomic amniocytes used in this study**DOI:** [http://dx.doi.org/10.7554/eLife.05068.003](10.7554/eLife.05068.003)NameKaryotypeGestational age (week)AF 146,XX17AF 246,XY20AF 346,XX21AF+13 147,XX,+1316AF+13 247,XX,+1321AF+13 347,XX,+1321AF+1847,XX,+1817AF+2147,XX,+211710.7554/eLife.05068.004Figure 1.Trisomy 7 and 13 in DLD1 and AF cells.(**A**--**B**) Chromosome-specific FISH staining for chromosomes 7 (red),13 (green), and 21 (red) in metaphase spreads confirms trisomy 7 in DLD1+7 and trisomy 13 in DLD1+13 and AF+13 cells. DNA is shown in grey. Arrows point to FISH signals. Scale bars, 5 μm. (**C**) Characterization of cells with trisomy 13 used in this study. The DLD1+13 cells were subcloned and the clone used for this study was analyzed by chromosome painting of metaphase spreads with chromosome 13-specific probes. Cells were classified as having lost chromosome 13, trisomic for chromosome 13, or poly/tetraploid when they carried six copies of chromosome 13 and ∼88 other chromosomes. The AF+13 cells were analyzed by interphase FISH at passage 1--2 with probes specific to chromosomes 13 and 21. Cells were classified has having lost/gained a copy of chromosome 13 (two or four nuclear signals for chr. 13, two signals for chr. 21), displaying trisomy 13 (three signals for chr. 13 and 2 signals for chr. 21), or displaying poly/tetraploidy (six signals for chr. 13 and four signals for chr. 21). A small fraction (1.9%) of the AF+13 Case \#3 displayed loss/gain of chr. 21.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.004](10.7554/eLife.05068.004)10.7554/eLife.05068.005Figure 1---figure supplement 1.aCGH in DLD1, DLD1+7, and DLD1+13 cells.(**A**--**C**) The images show the results of aCGH in the three cell lines, with regions shaded in blue corresponding to gains and regions shaded in red corresponding to losses. The data show that the DLD1+7 and DLD1+13 cell lines share CNVs, such as duplication of a portion of the short arm of chromosome 2, gain of a short portion of the p arm of chromosome 11, and loss of a short region of the p arm of chromosome 6, with the parental cell line. Moreover, the data highlight the gain of most of the q arm of chromosome 7 in the DLD1+7 cell line and gain of chromosome 13 in the DLD1+13 cell line. (**D**) 2× enlargement of the aCGH image of chr. 7 from the DLD1+7 cell line. (**E**) FISH staining of DLD1+7 metaphase spread using a probe (red) specific to the centromeric DNA of chromosome 7. The image shows that the trisomic chromosome 7q maintains a centromere. DNA is shown in grey. Arrows point to FISH signals. (**F**) 2× enlargement of the aCGH image of chr. 13 from the DLD1+13 cell line.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.005](10.7554/eLife.05068.005)

Increased chromosome mis-segregation in cells with trisomy 7 or 13 {#s2-1}
------------------------------------------------------------------

To investigate the effect of aneuploidy on chromosome segregation, we analyzed anaphase lagging chromosomes, a common cause of aneuploidy in normal and cancer cells ([@bib12]; [@bib66]). By analyzing fixed cells with immunostained kinetochores and microtubules, we found that DLD1+7 and DLD1+13 cells displayed significantly higher frequencies of anaphase lagging chromosomes compared to the parental DLD1 cell line ([Figure 2A--B](#fig2){ref-type="fig"}). We found no evidence of aneuploidy-dependent increases in other mitotic defects, such as multipolar mitoses and anaphase chromosome bridges ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Frequencies of anaphase lagging chromosomes in AF and AF+13 cells could not be analyzed in fixed samples due to low mitotic indices. However, we optimized live-cell imaging of AF and AF+13 cells expressing H2B-GFP/RFP-tubulin ([Figure 2C](#fig2){ref-type="fig"}; [Videos 1--2](#video1 video2){ref-type="other"}) and found higher frequencies of anaphase lagging chromosomes in AF+13 compared to AF cells ([Figure 2D](#fig2){ref-type="fig"}). Anaphase chromosome bridges or multipolarity were never observed in AF or AF+13 cells.10.7554/eLife.05068.006Figure 2.Increased rates of anaphase lagging chromosomes in cells with trisomy 7 or 13.(**A**) Examples of normal anaphases (top row) and anaphase cells with lagging chromosomes (bottom row). Cells were immunostained for microtubules (red) and kinetochores (green). DNA is shown in blue. Images represent maximum intensity projections of Z-stacks. Arrowheads point at anaphase lagging chromosomes. Grey scale images at the bottom right corners of the images in the bottom row are single focal planes of DAPI-stained chromosomes shown for easier visualization of the lagging chromosomes. (**B**) Frequencies of anaphase lagging chromosomes were significantly higher (\*χ^2^ test, p \< 0.0001) in both DLD1+7 and DLD1+13 compared to DLD1 cells. Data are reported as mean ± S.E.M and represent the average of three independent experiments in which a total of 613--1115 anaphases were analyzed. (**C**) Time-lapse microscopy of AF and AF+13 cells undergoing mitosis. An example of AF undergoing normal mitosis is shown in the top row and an example of AF+13 displaying an anaphase lagging chromosome is shown in the bottom row. DNA is shown in green (H2B-GFP) and microtubules in red (RFP-tubulin). Images are maximum intensity projections of Z-stacks. Insets in the bottom row display enlarged views of the DNA alone (in grey scale) in the region around the lagging chromosome. (**D**) None of the 19 AF cells (from cases \#1 and \#2) imaged displayed anaphase lagging chromosomes, whereas 7 out of 26 AF+13 cells (5 out of 18 in case \#1 and 3 out of 8 in case \#2) displayed anaphase lagging chromosomes. Time stamps indicate elapsed time in min:sec. Scale bars, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.006](10.7554/eLife.05068.006)10.7554/eLife.05068.007Figure 2---figure supplement 1.Similar frequencies of multipolar mitoses (**A**) and anaphase chromosome bridges (**B**) in diploid vs aneuploid DLD1 cells.The data are reported as mean ± S.E.M. and represent the average of three experiments in which a total of 931--1179 mitotic cells (**A**) or 616--1190 anaphase cells (**B**) were analyzed.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.007](10.7554/eLife.05068.007)Video 1.Representative video showing normal mitosis in an AF cell.Images were acquired by spinning-disk confocal microscopy at 1 min intervals and they are played back at 5 frames per second. DNA is shown in green (H2B-GFP) and microtubules in red (RFP-tubulin).**DOI:** [http://dx.doi.org/10.7554/eLife.05068.008](10.7554/eLife.05068.008)10.7554/eLife.05068.008Video 2.Representative video showing anaphase lagging chromosome during mitosis in an AF+13 cell.Images were acquired by spinning-disk confocal microscopy at 1 min intervals and they are played back at 5 frames per second. DNA is shown green (H2B-GFP) and microtubules in red (RFP-tubulin).**DOI:** [http://dx.doi.org/10.7554/eLife.05068.009](10.7554/eLife.05068.009)10.7554/eLife.05068.009

As an additional method to measure chromosome mis-segregation and to account for events in which two sister chromatids co-segregate to the same spindle pole/daughter cell, we combined the cytokinesis-block assay ([@bib19]) with FISH staining using locus-specific probes for chromosomes 3, 7, 11, and 13 in DLD1 cell lines, and probes specific for chromosomes 7, 11, 12, 13, 18, and 19 in amniocytes. Using this approach, which allows analysis of the reciprocal distribution of chromosomes between the daughter nuclei of a single mitotic division ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), we found a significant increase in chromosome mis-segregation in DLD1+7, DLD1+13, and AF+13 compared to the corresponding diploid cell cultures ([Figure 3B--C](#fig3){ref-type="fig"}). However, the higher mis-segregation rates were specific to certain chromosomes. Namely, mis-segregation appeared to be increased for chromosome 7 in the DLD1+7 cell line, chromosomes 7 and 13 in DLD1+13 cells, and chromosome 13 in AF+13 cells as compared to their diploid counterparts. We further investigated whether the observed increases in chromosome mis-segregation rates impacted chromosome number variability (or karyotypic heterogeneity) in the trisomic cells compared to the diploid counterparts. To this end, we performed chromosome counts in metaphase spreads and found increased karyotypic heterogeneity in both DLD1+7 and DLD1+13 compared to DLD1 cells. We also found higher karyotypic heterogeneity in AF+13 vs AF cells around the modal chromosome number of 47 ([Figure 3D](#fig3){ref-type="fig"}). Finally, our chromosome counts revealed the presence of a tetraploid/near-tetraploid sub-population in DLD1+13 cells ([Figure 3D](#fig3){ref-type="fig"}), confirming previous findings ([@bib69]). Because chromosome counts did not reveal a significant difference in tetraploid cells between AF and AF+13 cell populations ([Figure 3D](#fig3){ref-type="fig"}), we decided to further characterize chromosome number variability in these cells by performing FISH analysis with locus-specific probes for chromosomes 7, 12, and 18 on interphase nuclei ([Figure 3E](#fig3){ref-type="fig"}), which allowed for larger numbers of cells to be examined. This analysis confirmed higher degrees of aneuploidy in AF+13 compared to AF cells ([Figure 3F](#fig3){ref-type="fig"}). Furthermore, it revealed the presence of a tetraploid sub-population in AF+13 cells ([Figure 3F](#fig3){ref-type="fig"}). The difference between numbers of AF+13 tetraploid interphase cells and tetraploid chromosome spreads (compare [Figure 3D](#fig3){ref-type="fig"} and [Figure 3F](#fig3){ref-type="fig"}) may be due to the inability of tetraploid AF+13 cells to re-enter mitosis (see also 'Discussion' section). Taken together, these experiments ([Figures 2--3](#fig2 fig3){ref-type="fig"}) show that trisomies 7 and 13 cause chromosome mis-segregation, that mis-segregation affects certain chromosomes more than others, and that such increases in mis-segregation rates are associated with karyotypic heterogeneity within the cell population. However, because only trisomies 7 and 13 were examined, and a limited number of chromosomes analyzed in our FISH experiments, it remains elusive whether chromosome mis-segregation is a karyotype-specific or a general effect of aneuploidy in human cells.10.7554/eLife.05068.010Figure 3.Increased chromosome mis-segregation rates and karyotypic heterogeneity in cells with trisomy 7 or 13.(**A**--**C**) Combination of cytokinesis-block assay and FISH staining with chromosome-specific probes shows higher chromosome mis-segregation rates in DLD1+7 and DLD1+13 compared to DLD1 cells and AF+13 compared to AF cells. (**A**) Examples of FISH-stained binucleate (BN) DLD1 and DLD1+13 cells. Scale bar, 5 μm. (**B**--**C**) Frequencies of BN cells displaying mis-segregation events. \*Two-tailed χ^2^ test, p \< 0.005; \*\*two-tailed χ^2^ test, p \< 0.0001, when compared to mis-segregation of the same chromosome in the euploid cell line. Data are presented as mean ± S.E.M. and represent the average of at least three independent experiments/samples in which a total of 460--1229 BN cells were analyzed. (**D**) Beeswarm plot displaying data from chromosome counts in metaphase spreads from the five cell lines. DLD1+7, DLD1+13, and AF+13 (modal chromosome number 47, shown by the high concentration of sampled points) displayed increased karyotypic heterogeneity compared to DLD1 and AF cells (modal chromosome number 46, shown by the high concentration of sampled points), respectively. In addition, DLD1+13 cells displayed a large sub-population of near-tetraploid cells (modal chromosome number 92). Chromosome counts were performed on 89--303 metaphase spreads. (**E**--**F**) FISH staining with chromosome-specific probes in interphase nuclei reveals higher rates of aneuploidy and tetraploidy in AF+13 vs AF cells. (**E**) FISH staining in interphase AF and AF+13 cells with probes specific for chromosomes 7 (blue), 12 (green), and 18 (red). Scale bar, 5 μm. (**F**) Quantification of interphase FISH data shown in (**E**). Cells were classified as having gained or lost 1-few chromosomes or as tetraploid (4 signals for each of the three chromosomes analyzed). The data show a larger fraction of cells with gain/loss of 1-few chromosomes in the AF+13 population compared to AF cells (\*χ^2^ test, p \< 0.0001). Additionally, AF+13 cells displayed a larger sub-population of tetraploid cells (\*χ^2^ test, p \< 0.0001). Data are presented as mean + S.E.M. and represent the average of three different samples in which a total of 2,117--2,410 cells were analyzed.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.010](10.7554/eLife.05068.010)10.7554/eLife.05068.011Figure 3---figure supplement 1.Combined cytokinesis-block assay and FISH staining with chromosome-specific probes.The images show examples of binucleate AF, AF+13, and DLD1+7 cells hybridized with FISH probes specific to chromosomes 11 and 13. Green arrows in image of mis-segregation in AF+13 cell point at signals for chromosome 13. Scale bar, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.011](10.7554/eLife.05068.011)

Trisomy 13 promotes cytokinesis failure due to the overexpression of SPG20 {#s2-2}
--------------------------------------------------------------------------

Our chromosome counts ([Figure 3D](#fig3){ref-type="fig"}) showed that DLD1+13 cells displayed a near-tetraploid sub-population, which was also evident in our FISH experiments in which nuclei with four or more signals per chromosome were more frequent in DLD1+13 compared to DLD1 cells (24.5% vs 16.6%, χ^2^, p \< 0.0001). Similarly, a tetraploid sub-population was evident in AF+13 cells (4.5% vs 0.3% in AF, χ^2^, p \< 0.0001) analyzed by interphase FISH, which revealed the presence of nuclei with four signals per chromosome ([Figure 3E--F](#fig3){ref-type="fig"}). These observations suggested a possible causal link between trisomy 13 and tetraploidy. Acknowledged mechanisms of tetraploidy induction include mitotic slippage ([@bib54]), cytokinesis failure ([@bib43]), and cell fusion ([@bib15]). To determine which of these mechanisms cause tetraploidy in DLD1+13 and AF+13 cells, we performed phase contrast time-lapse microscopy and found no evidence of mitotic slippage or cell fusion. Instead, we found that both DLD1+13 and AF+13 cells failed cytokinesis ([Figure 4A--B](#fig4){ref-type="fig"}, [Videos 3--6](#video3 video4 video5 video6){ref-type="other"}) at significantly higher rates than their diploid counterparts ([Figure 4C](#fig4){ref-type="fig"}). To identify the molecular mechanism that causes cytokinesis failure in cells with trisomy 13, we referred to microarray data available for DLD1+13 cells ([@bib69]). Interestingly, located on chromosome 13q13.3 is the gene *SPG20*, which encodes for the protein Spartin, previously suggested to act as a regulator of cytokinesis ([@bib51]; [@bib35]), and shown to be overexpressed in DLD1+13 compared to DLD1 cells ([@bib69]). None of the other mis-expressed genes ([@bib69]) was found to have any link with cytokinesis based on published data. We confirmed SPG20 overexpression by western blot in both DLD1+13 and AF+13 cells ([Figure 4D--F](#fig4){ref-type="fig"}). Importantly, neither DLD1+7 ([Figure 4E](#fig4){ref-type="fig"}) nor other trisomic AF cells ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}) overexpressed spartin, indicating that high levels of spartin are specifically associated with trisomy 13.10.7554/eLife.05068.012Figure 4.DLD1+13 and AF+13 cells overexpress SPG20 and fail cytokinesis at high rates.(**A**--**B**) Time-lapse microscopy indicates that cells with trisomy 13 frequently fail cytokinesis. Time stamps indicate elapsed time in minutes. Scale bars, 10 μm. (**A**) Still images from time-lapse phase contrast videos of DLD1+13 cells undergoing mitosis and completing (top row) or failing (bottom row) cytokinesis. (**B**) Still images from time-lapse phase contrast videos of AF (top row) and AF+13 (bottom row) cells undergoing mitosis and completing (AF, top row) or failing (AF+13, bottom row) cytokinesis. (**C**) Quantification of cytokinesis failure from phase-contrast time-lapse videos showing that the rates of cytokinesis failure in DLD1+13 and AF+13 cells are significantly higher than those observed in their diploid counterparts, DLD1 and AF cells (\*χ^2^ test, p \< 0.01; \*\* χ^2^ test, p \< 0.001). (**D**) Western blot analysis of Spartin across DLD1 cell lines, three samples of AF and three samples of AF+13 cells. β-actin was used as a loading control. (**E**) Quantification of spartin levels (normalized to β-actin) in DLD1, DLD1+7, and DLD1+13 cells. The data reported are the average of three independent experiments and are displayed as mean + S.E.M. (**F**) Quantification of spartin levels (normalized to β-actin) in AF and AF+13 cells. The data reported are the average of the three AF and AF+13 samples shown in (**E**) and are displayed as mean + S.E.M.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.012](10.7554/eLife.05068.012)10.7554/eLife.05068.013Figure 4---figure supplement 1.Trisomies other than 13 are not associated with spartin overexpression.(**A**) Western blot analysis of Spartin levels in AF control and AF+13, AF+18, and AF+21 trisomic cells. Spartin levels were normalized to β-actin and are shown as percentage of the amount in the euploid control. (**B**) Western blot with decreasing amounts (30, 20, and 10 μg) of total extracts from the trisomies used in (**A**) performed for titration of the western blot conditions.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.013](10.7554/eLife.05068.013)Video 3.Representative video showing normal cytokinesis in a DLD1+13 cell.Images were acquired by phase contrast microscopy at 2 min intervals, and they are played back at 7 frames per second. Scale bar, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.014](10.7554/eLife.05068.014)10.7554/eLife.05068.014Video 4.Representative video showing cytokinesis failure in a DLD1+13 cell.Images were acquired by phase contrast microscopy at 2 min intervals, and they are played back at 7 frames per second. Scale bar, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.015](10.7554/eLife.05068.015)10.7554/eLife.05068.015Video 5.Representative video showing normal cytokinesis in an AF cell.Images were acquired by phase contrast microscopy at 2.5 min intervals, and they are played back at 5 frames per second. Scale bar, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.016](10.7554/eLife.05068.016)10.7554/eLife.05068.016Video 6.Representative video showing cytokinesis failure in an AF+13 cell.Images were acquired by phase contrast microscopy at 2.5 min intervals, and they are played back at 5 frames per second. Scale bar, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.017](10.7554/eLife.05068.017)10.7554/eLife.05068.017

To test whether *SPG20* overexpression could explain the cytokinesis-failure phenotype, we transfected the parental cell line DLD1 with YFP-SPG20 (DLD1-YFP-SPG20; [Figure 5A](#fig5){ref-type="fig"}, [Videos 7--8](#video7 video8){ref-type="other"}), and found that high levels of Spartin ([Figure 5B](#fig5){ref-type="fig"}) induced high rates of cytokinesis failure ([Figure 5C](#fig5){ref-type="fig"}). Moreover, we could rescue the cytokinesis failure phenotype in both DLD1+13 and AF+13 cells by siRNA-mediated Spartin knockdown ([Figure 5D--G](#fig5){ref-type="fig"}). Thus, we conclude that the aneuploidy-dependent overexpression of Spartin in DLD1+13 and AF+13 cells induces cytokinesis failure, a karyotype-dependent phenotype.10.7554/eLife.05068.018Figure 5.Spartin overexpression induces cytokinesis failure.(**A**) Time-lapse microscopy of DLD1 cells transiently transfected with a YFP-N1 vector (DLD1-YFP, top row) or a YFP-SPG20-N1 vector (DLD1-YFP-SPG20, bottom row). Representative still images of time-lapse videos show a DLD1-YFP cell undergoing mitosis and completing cytokinesis (top row) and a DLD1-YFP-SPG20 cell undergoing mitosis and failing cytokinesis (bottom row). YFP expression was verified by fluorescence imaging and it is shown in the first panel for each time-lapse series. A copy of the last frame was added at the end of the sequence to highlight cell (yellow) and nuclear (green) outlines. Scale bar, 10 μm. (**B**) Western blot analysis of Spartin levels in DLD1+13, DLD1-YFP, and DLD1-YFP-SPG20 cells shows that the levels of YFP-Spartin in DLD1-YFP-SPG20 cells (center lane) are much higher than the levels of Spartin in DLD1-YFP cells. WB of Spartin in DLD1+13 cells is shown for comparison. (**C**) Quantification of cytokinesis failure rates in DLD1-YFP and DLD1-YFP-SPG20 showing that overexpression of SPG20 leads to increased rates of cytokinesis failure (\*χ^2^ test, p \< 0.01 when comparing DLD1-YFP-SPG20 to DLD1-YFP cells). (**D**) Western blot analysis of Spartin levels in DLD1+13 cells treated with a SPG20 siRNA or with a control siRNA. (**E**) Reducing the levels of Spartin by SPG20 siRNA significantly reduces the rate of cytokinesis failure in DLD1+13 cells (\*χ^2^ test, p \< 0.02 when comparing cells treated with a control siRNA to cells treated with SPG20 siRNA). (**F**) Western blot analysis of Spartin levels in AF+13 cells treated with a SPG20 siRNA or with a control siRNA. (**G**) Reducing the levels of Spartin by SPG20 siRNA significantly reduces the rates of cytokinesis failure in AF+13 cells (\*χ^2^ test, p \< 0.02 when comparing cells treated with a control siRNA to cells treated with SPG20 siRNA). Average values from three independent experiments; variability between AF+13 samples was not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.018](10.7554/eLife.05068.018)Video 7.Representative video showing normal cytokinesis in a DLD1 cell transiently transfected with a YFP vector (control).Near-simultaneous phase contrast and epifluorescence images were acquired at 4 min intervals at a single focal plane using the Nikon perfect focus function. For clarity, the fluorescent image is displayed only in the first frame, whereas the rest of the video shows only phase contrast images played back at 7 frames per second. Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.019](10.7554/eLife.05068.019)10.7554/eLife.05068.019Video 8.Representative video showing cytokinesis failure in a DLD1 cell transiently transfected with a YFP-SPG20 vector (SPG20 overexpression).Near-simultaneous phase contrast and epifluorescence images were acquired at 4 min intervals at a single focal plane using the Nikon perfect focus function. For clarity, the fluorescent image is displayed only in the first frame, whereas the rest of the video shows only phase contrast images played back at 7 frames per second. Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.020](10.7554/eLife.05068.020)10.7554/eLife.05068.020

How does spartin overexpression induce cytokinesis failure? {#s2-3}
-----------------------------------------------------------

To determine how Spartin overexpression may lead to cytokinesis failure, we analyzed the amount and localization of Spartin in fixed DLD1 cells ([Figure 6A--B](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Spartin localized to the centrosomes throughout mitosis and to some extent along the microtubules of the mitotic spindle ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), and localized to the midbody during cytokinesis ([Figure 6A](#fig6){ref-type="fig"}), as previously described ([@bib35]). We quantified the total intracellular amount of Spartin by measuring total Spartin fluorescence intensity in interphase cells, and found that it was significantly higher in DLD1+13 cells compared to DLD1 cells ([Figure 6B](#fig6){ref-type="fig"}; see also [Figure 4D](#fig4){ref-type="fig"}). However, we did not observe any difference in Spartin localization between the two cell lines during mitosis ([Figure 6A](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), although there was clearly a large amount of Spartin in the cytoplasm, away from the mitotic spindle, in DLD1+13, but not in the other cell lines ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Thus, although Spartin overexpression induces cytokinesis failure ([Figure 5A--C](#fig5){ref-type="fig"}), the mechanism by which this happens is not simply mis-localization of Spartin at the midbody ([Figure 6A](#fig6){ref-type="fig"}).10.7554/eLife.05068.021Figure 6.Spartin overexpression impairs Spastin localization to the midbody.(**A**--**B**) Spartin localization at the midbody is not affected by the high levels of intracellular Spartin in DLD1+13. (**A**) Images showing Spartin localization (arrows) at the midbody of the three DLD1 cell lines. (**B**) The image shows interphase DLD1+13 cells immunostained for Spartin and the yellow and white outline indicate the regions of interest (ROI) selected for measurements of total intracellular fluorescence (yellow ROI) and background fluorescence (white ROI). The data in the graph report the total intracellular Spartin fluorescence intensity after background subtraction in randomly sampled interphase cells and are represented as mean ± S.E.M (\*t-test, p \< 0.0001 when comparing DLD1+13 to either DLD1 or DLD1+7). (**C**) Superimposition of the MIT domains of Spartin (orange) and Spastin (cyan) illustrates the considerable degree of structural homology between the two. PDB ID \#2DL1 ([@bib65]) and \#3EAB ([@bib76]) for Spartin and Spastin, respectively. (**D**--**E**) Spastin localization at the midbody is impaired in DLD1+13 cells, and is rescued by SPG20 siRNA. (**D**) Images of midbodies of cells immunostained for Spastin (green) and microtubules (red). Arrows point at sites of Spastin localization or lack thereof. (**E**) Frequencies of cells lacking Spastin at the midbody. Higher frequencies of cells lacking Spastin at the midbody can be found in DLD1+13 cells compared to either DLD1 or DLD1+7 cells. Spastin localization could be rescued by knocking down Spartin levels in DLD1+13 cells via SPG20 siRNA. Statistical significance was calculated using a χ^2^ test (\*p \< 0.05; \*\*p \< 0.01; N.S. = not significant). Data are presented as mean ± S.E.M. and represent the average of three independent experiments. (**F**--**G**) Spastin localization at the midbody is impaired in AF+13 cells, and is partially rescued by SPG20 siRNA. (**F**) Images of midbodies of cells immunostained for Spastin (green) and microtubules (red). DNA is shown in blue in the merged images. Arrows point at sites of Spastin localization or lack thereof. The insets show 3× magnifications of the midbody region. (**G**) Frequencies of cells lacking Spastin at the midbody are higher in AF+13 compared to AF cells. Spastin localization was partially rescued by SPG20 siRNA-mediated Spartin knock down in AF+13 cells. Statistical significance was calculated using a χ^2^ test (\*p \< 0.05; \*\*\*p \< 0.001; \*\*\*\*p \< 0.0001). Data are presented as mean ± S.E.M. and represent the average of three independent experiments/samples. Scale bars, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.021](10.7554/eLife.05068.021)10.7554/eLife.05068.022Figure 6---figure supplement 1.Spartin localization during mitosis.Cells were immunostained for Spartin (green) and microtubules (red) and counterstained with DAPI for DNA (blue). For each cell line, the merged images (top) and Spartin alone (bottom) are shown. Images are maximum intensity projections of Z-stacks. Spartin localizes to the spindle poles during prometaphase, metaphase, and anaphase in DLD1, DLD1+7 and DLD1+13. An eccess of cytoplasmic spartin (away from the mitotic spindle) can be noticed in DLD1+13 cells, but not in the other two cell lines. Scale bar, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05068.022](10.7554/eLife.05068.022)

Spartin is recruited to the midbody by binding hIST1 ([@bib51]), a component of the ESCRTIII complex, which binds various proteins involved in cytokinesis, including the microtubule severing protein Spastin ([@bib51]), whose depletion was shown to cause cytokinesis failure ([@bib2]). Both Spartin and Spastin bind hIST1 through their MIT (Microtubule Interacting and Trafficking) domains, which show considerable structural homology ([Figure 6C](#fig6){ref-type="fig"}) and comparable binding affinities (Spartin, K~d~ = 10.4 ± 0.3 μM, Spastin, K~d~ = 4.6 ± 0.1 μM, respectively \[[@bib51]\]). Therefore, we postulated that Spartin overexpression might act in a dominant negative manner by preventing Spastin from binding to hIST1. To test this, we analyzed Spastin localization at the midbody. Consistent with our hypothesis, DLD1+13 and AF+13 cells frequently lacked Spastin at the midbody ([Figure 6D--G](#fig6){ref-type="fig"}). Moreover, by knocking down Spartin we could rescue Spastin mis-localization fully in DLD1+13 ([Figure 6E](#fig6){ref-type="fig"}) and partially in AF+13 cells ([Figure 6G](#fig6){ref-type="fig"}).

In summary, we showed that overexpression of SPG20, a gene on chromosome 13 encoding the protein Spartin, can cause cytokinesis failure in cells with trisomy 13 ([Figures 4--5](#fig4 fig5){ref-type="fig"}). Although Spartin overexpression may cause cytokinesis failure by interfering with multiple pathways, here we provide evidence of interference with a pathway responsible for Spastin localization at the midbody ([Figure 6D--G](#fig6){ref-type="fig"}).

Discussion {#s3}
==========

Chromosomal instability in trisomic cells {#s3-1}
-----------------------------------------

We show here that cells with trisomy 7 or trisomy 13 display rates of anaphase lagging chromosomes that are significantly higher than the rates observed in euploid counterparts. Anaphase lagging chromosomes are a major source of aneuploidy in normal vertebrate cells ([@bib12]) and the main type of chromosome segregation defect observed in CIN cancer cells ([@bib66]; [@bib3]). Previous studies have shown that anaphase lagging chromosomes can be caused by transient spindle multipolarity in CIN cancer cells ([@bib22]; [@bib61]; [@bib60]). However, we can exclude transient multipolarity as a cause of anaphase lagging chromosomes in our experimental systems, given that we did not find differences in the frequencies of multipolar mitoses in DLD1+7 and DLD1+13 compared to DLD1 cells and we did not observe transient spindle multipolarity in live AF+13. This finding may seem surprising, particularly considering that we found trisomy 13 to be associated with cytokinesis failure, which is believed to result in extra centrosomes and multipolar mitoses ([@bib63]; [@bib21]). However, this finding is in agreement with recent findings showing that experimental inhibition of cytokinesis can produce tetraploid cells with normal centrosome number ([@bib26]). Our finding that aneuploidy is associated with increased rates of anaphase lagging chromosomes, known to arise from errors in mitosis ([@bib3]), but not with multipolarity or chromosome bridges, known to arise from errors in centrosome duplication or DNA metabolism (occurring prior to mitosis), suggests that compared to events occurring during other cell cycle stages, mitotic events may be more sensitive to the gene imbalance brought about by aneuploidy. Although abnormal chromosome number was reported by others as not being sufficient to cause CIN ([@bib33]; [@bib72]), such difference may be due to the different methods used to evaluate CIN. For example, whereas we examined chromosome mis-segregation in mitosis (anaphase lagging chromosomes) or at a post-mitotic interphase (BN cell analysis), Lengauer and colleagues determined the degree of aneuploidy in the overall population after 25 serial passages ([@bib33]). This kind of analysis may produce a biased result because selective pressure against arising aneuploid cells may mask the ability of aneuploidy to induce chromosome mis-segregation at each cell cycle. Importantly, we were able to perform high-resolution live cell imaging of individual human amniocytes with constitutional trisomy 13 at passage number 2--3 and directly measure how frequently chromosome mis-segregation events occur. The frequency of lagging chromosomes found in mitotic cells was considerably higher compared to the frequency of chromosome mis-segregation measured by FISH analysis both in interphase and post-mitotic fixed cells. This shows how different results are generated from distinct methods and might also explain the divergence between our data and those previously reported by [@bib72] using interphase FISH analysis. It should also be noted that, although we do observe an increase in the rates of anaphase lagging chromosomes in trisomic cells, such rates are lower than those reported for most CIN cancer cell lines ([@bib66]; [@bib40]; [@bib3]), in agreement with findings by [@bib72]. This suggests that, although single chromosome gains may result in only modest increases in chromosome mis-segregation rates, the high degrees of aneuploidy typical of most cancer cells may have a cumulative effect and could thus explain the high rates of CIN displayed by many cancer cells (e.g., 20--75% anaphase lagging chromosomes in cells with modal chromosome number 66--78; \[[@bib33]; [@bib66]; [@bib22]; [@bib61]; [@bib39], [@bib40]\]). Finally, and perhaps most importantly, the discrepancies in the conclusions reached in different studies may depend on the specific chromosomes analyzed. Indeed, we find that the degree and type of CIN elicited by aneuploidy depend on the aneuploid chromosome (see [Figure 3D](#fig3){ref-type="fig"}). This is an agreement with findings in aneuploid budding yeast strains, in which different aneuploidies were found to result in different rates of chromosome loss/CIN ([@bib58]; [@bib77]). Similarly, Valind and colleagues reported increased rates of CIN for certain chromosomes in specific aneuploid contexts (e.g., increased CIN for chromosome 17 in cells with trisomy 18), but not in others ([@bib72]). In our study, we specifically found that high rates of mis-segregation for chromosome 7 were observed both in DLD1+7 and DLD1+13 cells, whereas high mis-segregation for chromosome 13 was observed in DLD1+13 and AF+13 cells. The observation that the trisomic chromosome displayed the highest rates of mis-segregation across the trisomies studied ([Figure 3B--C](#fig3){ref-type="fig"}) suggests that the aneuploid chromosomes may undergo changes that affect their mitotic behavior and segregation, such as delayed replication and/or delayed condensation timing (DRT and DCT, respectively). Indeed, aneuploidy was shown to correlate with DRT and DCT ([@bib28]) and previous studies in trisomic cells showed that one of the chromosomes of the trisomic set displays DRT ([@bib30]). On the other hand, the finding that chromosome 7 mis-segregated in DLD1+13, but not in AF+13 cells raises the question as to whether types and rates of mis-segregation may vary in a cell type-dependent manner and whether copy number variations in the DLD1-derived cell lines may account for chromosome 7 mis-segregation. Given that the gain of chromosome 7 and chromosome 13 is commonly found in colon cancer ([@bib52]), a cell type-specific effect is plausible.

Although our cytokinesis-block assay data ([Figure 3B--C](#fig3){ref-type="fig"}) show the higher mis-segregation rates to be limited to certain chromosomes, the chromosome count data show extensive karyotypic heterogeneity in the trisomic cell populations ([Figure 3D--F](#fig3){ref-type="fig"}), thus suggesting that chromosome mis-segregation is more widespread than the cytokinesis-block assay reveals. One explanation is that the limited number of cells and chromosomes analyzed in the cytokinesis-block assay might only reveal differences in mis-segregation rates when such differences are large, but other methods, such as anaphase lagging chromosomes may be a better indicator of general mis-segregation rates. Moreover, some mis-segregation events may result in cell cycle arrest or cell death. Cases of chromosome mis-segregation leading to cell death would only be accounted for when examining cells undergoing mitosis, but not interphase cells. On the other hand, chromosome mis-segregation events leading to cell cycle arrest may only be appreciated when examining interphase nuclei, but not BN or mitotic cells ([Figure 3D--F](#fig3){ref-type="fig"}). These considerations argue for the use of multiple assays in studies aimed at dissecting the link between aneuploidy and CIN ([@bib41]). We would also like to point out that chromosome mis-segregation events causing cell death or cell cycle arrest under tissue culture conditions, may not do so in the context of the tumor environment, suggesting that low level aneuploidy could be enough to drive CIN in cancer. Indeed, our data show that the complex aneuploidies observed in cancer cells are not a requirement for increased rates of lagging chromosomes and that at least some low grade and constitutional aneuploidies are sufficient to induce such an effect. This would be in agreement with previous observations showing that haploid budding yeast strains carrying disomies displayed increased genomic instability, and strains with different degrees of aneuploidy displayed variable degrees of chromosomal instability ([@bib58]; [@bib77]). Similarly, previous reports have shown that lymphocytes of congenitally trisomic individuals displayed aneuploidies for chromosomes other than the congenitally trisomic ones ([@bib49], [@bib50]). Finally, random aneuploidy and senescent phenotypes were recently reported in aneuploid amniocytes ([@bib6]). Nonetheless, we do not exclude the possibility that certain aneuploidies may not be sufficient to induce chromosome mis-segregation.

Aneuploidy confers karyotype-dependent phenotypes {#s3-2}
-------------------------------------------------

Our finding that trisomy 13 caused a specific cytokinesis failure phenotype ([Figures 4--5](#fig4 fig5){ref-type="fig"}) clearly indicates that different karyotypes can be associated with distinct phenotypic changes. It is important to note that, although we observed cytokinesis failure in AF+13, the frequency of tetraploid metaphase spreads in these cells was very low, as opposed to the DLD1+13 cells ([Figure 3D](#fig3){ref-type="fig"}). This may be due to activation of a post-mitotic tetraploidy checkpoint in the AF+13 cells, but not in DLD1+13. Indeed, previous studies have shown a cell cycle arrest following cleavage failure in untransformed human cells ([@bib1]; [@bib31]), whereas transformed cells continue cycling ([@bib16]; [@bib45]), but the triggering of a p53-dependent arrest in tetraploid cells still remains a matter of debate ([@bib1]; [@bib64]; [@bib68]; [@bib21]; [@bib75]).

The observation that overexpression of a gene mapping on chromosome 13 is specifically linked to the cytokinesis failure phenotype in DLD1+13 and AF+13 cells demonstrates that there is a direct causal relationship between aneuploidy, overexpression of genes on the aneuploid chromosome, and phenotypic changes caused by the consequent proteomic imbalance. These findings support previous studies showing that aneuploidy directly affects transcript and protein levels in various systems in a karyotype-dependent manner ([@bib48]; [@bib69]; [@bib23]; [@bib47]; [@bib52]; [@bib62]; [@bib24]). Previous studies in budding yeast also showed that aneuploid strains displayed karyotype-specific phenotypic variations that conferred resistance to a variety of drugs ([@bib47]). However, such phenotypic variations in aneuploid yeast strains were only revealed when cells were grown under specific selective conditions ([@bib47]), whereas we show here that such karyotype-dependent phenotypic changes can be intrinsic to the aneuploid cells. Although some studies have shown that aneuploidy can have overall deleterious effects on cell fitness ([@bib67]; [@bib74]), we provide strong evidence that specific aneuploidies can also induce specific phenotypes, which could, under certain conditions, provide a selective advantage. This particular concept was recently exploited to demonstrate that in fungi, certain drug treatments can lead to the evolution of populations with defined aneuploid karyotypes ([@bib11]). In the particular case observed in our study, one could also envision how the increase in tolerance to aneuploidy that tetraploidy was recently shown to confer ([@bib14]) could enable the evolution of specific aneuploid karyotypes that may allow cells to overcome the detrimental impact of aneuploidy on cellular fitness ([@bib27]). Karyotype-specific phenotypic changes such as those observed in our study can also explain the recurrent aneuploidies that are found in tumors from certain anatomical sites (e.g., gain of chromosome 13 and loss of chromosome 18 in colon cancer \[[@bib53], [@bib52]; [@bib40]\]). Indeed, aneuploidies for certain chromosomes may result in phenotypes that confer a selective advantage at a certain site (e.g., breast), but not at a different one (e.g., colon). And this could explain why, despite the high degrees of aneuploidy and the extensive karyotypic heterogeneity, the distribution of aneuploidies in different cancers is not completely random ([@bib39]; [@bib52]).

Materials and methods {#s4}
=====================

Cell lines and culture conditions {#s4-1}
---------------------------------

The DLD1 cell line was obtained from American Type Culture Collection (ATCC, BA, USA), DLD1+7 and DLD1+13 cell lines were created previously by microcell-mediated chromosome transfer as described in ([@bib69]), and DLD1+13 cells were sub-cloned for this study as described in the results section. All cell lines were maintained in RPMI 1640 (ATCC, BA, USA) supplemented with 10% FBS (Gibco, Life Technologies, CA, USA), penicillin, streptomycin, and amphotericin B (antimycotic). Passage 1--3 fibroblast cultures were established from surplus amniocentesis samples used in pre-natal diagnosis. Three cases of constitutional trisomy 13 and three diploid controls were used in our study ([Table 1](#tbl1){ref-type="table"}). The study acknowledged the ethics guidelines under national rules and according to the principles of the Declaration of Helsinki, and was approved by the Ethics Committee of Hospital de S. João-Porto (dispatch 14 November 2012). Informed consent forms with detailed information were provided to all patients. The study did not imply collection of extra material from the healthy female donors (only surplus cells/tissues were used); the study did not bring any direct benefits to the volunteers; there were no risks or costs for the volunteers; there was no access to patient clinical data (samples were obtained in anonymous form from the Hospital Genetics Department); participation was volunteer and free to be interrupted at any moment; there are no ethical impacts predicted; there will be no commercial interests. Amniotic fibroblasts were grown in EMEM (Lonza, Bazel, Switzerland) supplemented with 15% FBS, 2.5 mM glutamine and 1× antibiotic-antimycotic solution (all from Gibco, Life Technologies, CA, USA). All cells were kept in a humidified incubator at 37°C with 5% CO~2~.

Immunostaining {#s4-2}
--------------

For immunostaining, DLD1 cells were grown on sterilized glass coverslips inside 35 mm Petri dishes, whereas AF cells were grown on sterilized glass coverslips coated with fibronectin (Sigma Aldrich, MO, USA). For analysis of anaphase lagging chromosomes in the DLD1 lines, cells were fixed in freshly prepared 4% paraformaldehyde in PHEM (60 mM Pipes, 25 mM HEPES, 10 mM EGTA, 2 mM MgSO~4~, pH 7.0) for 20 min at room temperature and then permeabilized for 10 min at room temperature in PHEM buffer containing 0.5% Triton-X 100. Following fixation and permeabilization, cells were washed with PBS 3 times and then blocked with 10% boiled goat serum (BGS) for 1 hr at room temperature. Cells were then incubated at 4°C overnight with primary antibodies diluted in 5% BGS. Cells were washed in PBS-T (PBS with 0.05% Tween 20) 3 times, and incubated at room temperature for 45 min with secondary antibodies diluted in 5% BGS. Cells were finally washed, stained with DAPI for 5 min, and coverslips were mounted on microscope slides in an antifade solution containing 90% glycerol and 0.5% N-propyl gallate. For analysis of proteins at the midbody, cells were fixed in ice cold methanol for 4 min, washed with PBS 3 times, and blocked in 10% BGS with 0.5% Triton-X for 1 hr. The rest of the procedure was the same as described above, except that primary antibodies were diluted in 1% BGS. Primary antibodies were diluted as follows: ACA (human anti-centromere protein, Antibodies Inc., CA, USA), 1:100; mouse anti-α-tubulin (DM1A, Sigma Aldrich, MO, USA), 1:500; rabbit anti-SPG20 (Protein Tech Group Inc., IL, USA), 1:300; mouse anti-Spastin (SP 3G11/1, Abcam, Cambridge, UK), 1:150. Secondary antibodies were diluted as follows: Rhodamine Red-X goat anti-mouse (Jackson ImmunoResearch Laboratories, Inc., PA, USA), 1:100; Rhodamine Red-X goat anti-rabbit (Jackson ImmunoResearch Laboratories, Inc., PA, USA), 1:100; Alexa 488 goat anti-human (Molecular Probes, Life Technologies, CA, USA), 1:200; Alexa 488 goat anti-mouse (Molecular Probes, Life Technologies, CA, USA), 1:200.

Metaphase spreads {#s4-3}
-----------------

Cell cultures were incubated in 50 ng/ml Colcemid (Karyomax, Invitrogen) at 37°C for 3--4 hr to enrich in mitotically arrested cells. The cells were then collected by trypsinization and centrifuged at 800 rpm for 8 min. Hypotonic solution (0.075M KCl) was added drop-wise to the cell pellet and incubated for 10 min at room temperature. Cells were fixed with an ice-cold 3:1 methanol:acetic acid solution for 5 min and then centrifuged at 800 rpm for 8 min. This last step was repeated two more times and fixed cells were finally dropped on microscope slides.

Cytokinesis-block assay and fluorescence in situ hybridization (FISH) {#s4-4}
---------------------------------------------------------------------

For FISH on binucleate cells, amniocytes were grown in superfrost ultra plus slides (Thermo Scientific, Life Technologies, CA, USA), whereas DLD1 cells were grown on coverslips. For the cytokinesis-block assay, cells were treated with 3 μg/ml dihydrocytochalasin B (Sigma--Aldrich, MO, USA) for 24 hr before fixation, and the experiment was repeated at least three independent times. Prior to being processed for FISH staining, cytokinesis-blocked cells were fixed according to previously published protocols: a standard FISH protocol ([@bib42]) was used for all cells; an alternative (3-D FISH) protocol ([@bib13]) was used in some experiments with DLD1, DLD1+7, and DLD1+13 cells. Bacterial artificial chromosome (BAC) contigs using three to six BAC sequences specific to each region were made for the following four probes: *CDX2* on chromosome 13q12, *MET* on chromosome 7q31, *CHEK1* on chromosome 11q24, and *TERC* on chromosome 3q26. The BAC clone contigs were labeled by nick translation with Spectrum Orange-dUTP (Abbott Laboratories; IL, USA) for CDX2, Dy-505-dUTP (Dyomics; Jena, Germany) for MET, Spectrum Orange-dUTP (Abbott Laboratories; IL, USA) for *CHEK1*, and Dy-505-dUTP (Dyomics; Jena, Germany) for *TERC*. Dual color human whole chromosome paint probes were generated in-house using PCR labeling techniques. Chromosome 7 was labeled with Spectrum Orange (Abbott Laboratories; Chicago, IL) and chromosome 13 was labeled with Dy505 (Dyomics; Jena, Germany). Additionally, commercial locus-specific FISH probes for chromosomes 7, 11, 19 (red 5-ROX dUTP) and 12, 13, 18 (green 5-fluorescein dUTP) were also used (Empire Genomics; Buffalo, NY, USA). The probe mixtures were co-denatured with the coverslips at 72°C for 5 min before being placed in a moist chamber at 37°C for two nights. After two nights, the coverslips were washed in 2XSSC for 5 min and then mounted on microscope slides with mounting media (Vectashield; CA, USA) and DAPI.

FISH on DLD1 metaphase spreads was performed with the commercial FISH probes listed above. Additionally, centromeric FISH probe against chromosome 7 (FITC) (Cytocell, Cambridge, UK) was used in DLD1+7 cells to confirm the presence of centromeric DNA. FISH on metaphase spreads of AF and AF+13 was performed with the XA 13/21 probe (MetaSystems, Germany) according to the manufacturer\'s instructions. Interphase FISH was performed with the Vysis centromeric probes CEP7 Spectrum Aqua, CEP12 Spectrum Green, and CEP18 Spectrum Orange (Abbott Molecular, IL, USA) according to the manufacturer\'s instructions. All the FISH-stained samples were analyzed blindly.

SPG20 transfection and SPG20 siRNA {#s4-5}
----------------------------------

DLD1 cells, grown on sterilized coverslips inside 35 mm Petri dishes, were transiently transfected with either P-EYFP-N1 or P-EYFP-N1-SPG20 (a kind gift from J Bakowska) using Fugene HD (Roche, Basel, Switzerland) according to the manufacturer\'s protocol. For SPG20 knockdown, cells grown in glass-bottom 35 mm u-dishes (Ibidi GmbH, Germany) or on sterilized coverslips inside 35 mm Petri dishes, were transfected with Silencer Select siRNA specific to SPG20 (S23057, Ambion, Life Technologies, CA, USA) using Oligofectamine according to the manufacturer\'s instructions (Invitrogen, Life Technologies, CA, USA). Silencer Select Negative control siRNA (Ambion, Life Technologies, CA, USA) was used as a negative control and was also transfected into cells with Oligofectamine (Invitrogen, Life Technologies, CA, USA). Cells were observed 48--72 hr after transfection.

Western blot analysis {#s4-6}
---------------------

Whole-cell extracts were separated by SDS-PAGE and transferred to PVDF membrane. Membranes were blocked 1 hr at room temperature with 5% milk in tris-buffered saline and then incubated over night with primary antibodies at 4°C. Antibodies were diluted as follows: rabbit anti-Spartin (Protein Tech Group Inc., IL, USA), 1:1000; rabbit anti-β-actin (Abcam, Cambridge, UK), 1:500. Blots were detected using goat anti-rabbit secondary antibodies conjugated to horse radish peroxidase and visualized with SuperSignal West Femto (Thermo Scientific, Life Technologies, CA, USA). A GS-800 calibrated densitometer, or alternatively a ChemiDoc XRS system, was used for quantitative analysis of protein levels with the help of ImageLab 4.1 software (BioRad, CA, USA).

Confocal microscopy of immunostained cells and image analysis {#s4-7}
-------------------------------------------------------------

Immunofluorescently labeled DLD1 cells were imaged with a swept field confocal system (Prairie Technologies, WI, USA) on a Nikon Eclipse TE2000-U inverted microscope (Nikon Instruments Inc., NY, USA) equipped with a 100×/1.4 NA Plan-Apochromatic objective and an automated ProScan stage (Prior Scientific, Cambridge, UK). The confocal head was accessorized with multiband pass filter set for illumination at 405, 488, 561, and 640 nm, and illumination was obtained through an Agilent monolithic laser combiner (MLC400) controlled by a four channel acousto-optic tunable filter. Digital images were acquired with a HQ2 CCD camera (Photometrics, AZ, USA). Acquisition time, Z-axis position, laser line power, and confocal system were all controlled by NIS Elements AR software (Nikon Instruments Inc., NY, USA) on a PC computer (Dell, TX, USA). Both anaphase lagging chromosomes and Spartin localization were analyzed by acquiring Z-sections of cells at 0.6 μm steps. The frequencies of anaphase lagging chromosomes were determined from 3 independent experiments performed in duplicate. Spartin localization at the midbody was determined from three independent experiments. Image acquisition of Spastin immunostaining in AFs was carried out on a Zeiss AxioImager Z1 equipped with an Axiocam MR and using a Plan-Apochromat 63×/1.4 NA objective. Images of telophase cells from three independent experiments and/or samples were acquired as Z-stacks with 0.3 μM steps and scored for the presence or absence of Spastin staining at the midbody. All data were analyzed blindly.

Microscopy and image analysis of FISH-stained binucleate cells {#s4-8}
--------------------------------------------------------------

FISH samples were viewed and imaged either with a Leica DM-RXA fluorescence microscope (Leica; Wetzlar, Germany) or with a swept field confocal system (Prairie Technologies, WI, USA) on a Nikon Eclipse TE2000-U inverted microscope (Nikon Instruments Inc., NY, USA). The Leica DM-RXA fluorescence microscope was equipped with custom optical filters and a 63×/1.3 NA objective. The Leica CW 4000 FISH software was used to acquire multifocal images for each fluorescence channel. 15 to 25 images were taken in areas of optimal cell density with minimal cellular clumps and overlapping cells. The Nikon Eclipse TE2000-U inverted microscope was equipped with a 100×/1.4 NA Plan-Apochromatic objective and an automated ProScan stage (Prior Scientific, Cambridge, UK). The confocal head was accessorized with a multiband pass filter set for illumination at 405, 488, 561, and 640 nm and illumination was obtained through an Agilent monolithic laser combiner (MLC400) controlled by a four channel acousto-optic tunable filter. Digital images were acquired with a HQ2 CCD camera (Photometrics, AZ, USA). Exposure time, Z-axis position, laser line power, and confocal system were all controlled by NIS Elements AR software (Nikon Instruments Inc., NY, USA) on a PC computer (Dell, TX, USA). FISH-stained samples were analyzed blindly and only cases with a total even number of signals were included in the analysis.

Phase contrast live cell imaging {#s4-9}
--------------------------------

DLD1, DLD1+7, and DLD1+13 cells were grown on sterilized coverslips inside 35 mm Petri dishes. Coverslips at 60--70% confluency were mounted in Rose chambers filled with L-15 medium supplemented with 4.5 g/l glucose. Images were acquired on a Nikon Eclipse Ti inverted microscope (Nikon Instruments Inc., NY, USA) equipped with phase-contrast transillumination, transmitted light shutter, ProScan automated stage (Prior Scientific, Cambridge, UK), and a HQ2 CCD camera (Photometrics, AZ, USA). Cells were maintained at ∼36°C using an air stream stage incubator (Nevtek, MA, USA). For analysis of cytokinesis in untransfected or siRNA-transfected cells, 10--15 different fields of cells were imaged every 2 min for 6--8 hr using a 60×/1.4 NA Plan-Apochromatic phase contrast objective controlled by Nikon Perfect Focus (Nikon Instruments Inc., NY, USA). For P-EYFP-N1 and P-EYFP-N1-SPG20 transfection experiments, 10--15 different fields of cells were imaged by fluorescence and phase contrast using a 20× or 60× objective every 4 min for 8 hr. The time-lapse videos were analyzed using NIS Elements AR (Nikon Instruments Inc., NY, USA) software on a PC computer (Dell, TX, USA).

Amniocytes were grown in glass-bottom 35 mm u-dishes (Ibidi GmbH, Germany) coated with fibronectin and filled with phenol red-free EMEM complete medium. Images were acquired on a Zeiss Axiovert 200M inverted microscope (Carl Zeiss, Germany) equipped with a CoolSnap camera (Roper, FL, USA), XY motorized stage and NanoPiezo Z stage, under controlled temperature, atmosphere and humidity. 20--25 neighbor fields were imaged every 2.5 min for 1--2 days using a 20×/0.3 NA A-Plan objective. Grids of neighboring fields were generated using the plugin Stitch Grid (Stephan Preibisch) from open source Fiji/Image J (<http://rsb.info.nih.gov/ij/>).

Spinning-disk confocal live cell imaging {#s4-10}
----------------------------------------

Amniotic cells, glass-bottom 35 mm u-dishes (Ibidi GmbH, Germany) coated with fibronectin, were co-transfected with H2B-GFP and pmRFP-tubulin expression plasmids (Addgene, MA, USA) using Lipofectamine 3000 transfection reagent and according to the manufacturer\'s instructions. Live cell imaging was performed 48 hr following transfection under a spinning-disk confocal system Andor Revolution XD (Andor Technology, UK) coupled to an Olympus IX81 inverted microscope (Olympus, UK) equipped with an electron-multiplying CCD iXonEM Camera and a Yokogawa CSU-22 unit based on an Olympus IX81 inverted microscope. Two laser lines at 488 and 561 nm were used for the excitation of GFP and pmRFP and the system was driven by IQ software (Andor Technology, UK). Z-stacks (0.8--1.0 μm) covering the entire volume of the mitotic cells were collected every 1.5 min with a PLANAPO 60×/1.4 NA objective. ImageJ was used to process all the videos.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Aneuploidy causes karyotype-dependent phenotypes in human cells" for consideration at *eLife*. Your article has been favorably evaluated by Stylianos Antonarakis (Senior editor), a Reviewing editor, and two reviewers.

The Reviewing editor and the reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

While both referees found your results interesting, they raised several concerns that are set out below. One referee commented that your mechanistic analysis of Spartin is interesting but based on two evidentiary leaps. First, that transient transfection of Spartin mimics the trisomic state, and second, that knockdown of Spartin mimics the disomic state. They suggested that you could strengthen this evidence using more specific techniques (lentiviral infection to introduce one copy of Spartin into the genome; CRISPR to remove one allele). These would undoubtedly strengthen your case but are substantial undertakings; therefore, in revising your study you should characterise your Spartin over expression and knock-down cell lines more carefully and discuss the potential caveats of your approaches.

Major points:

1\) The findings described here are at odds with the findings by [@bib72]. This study reported minimal chromosomal instability among aneuploid cells with eight different karyotypes. Only two different karyotypes are examined in this paper. This raises the question of the extent to which these results can be generalised.

2\) Two phenotypes of aneuploid cells are described in this manuscript: cytokinesis failure and the generation of lagging chromosomes. Are these two phenotypes related or distinct? Tetraploid cells are known to be chromosomally-unstable (e.g., Fujiwara, 2005). Are the lagging chromosomes in [Figure 2](#fig2){ref-type="fig"} occurring specifically in tetraploid cells? This could be tested by sorting a 2N population from each cell line and looking for laggards. FiFISH staining of chr. 7, 12 and 18 on interphase nuclei. How often are multipolar mitoses (which would be expected with the high frequency of tetraploidy) observed?

3\) How was the tetraploidy/near tetraploidy determined? In [Figure 3D](#fig3){ref-type="fig"}, there appear to be more tetraploid wild-type AF cells than tetraploid AF +13 cells. However, in [Figure 3F](#fig3){ref-type="fig"}, the opposite is shown. [Figure 3F](#fig3){ref-type="fig"} shows that at least 5 % of AF+13 cells are tetraploid/near tetraploid without explaining how were these number obtained. In the text it appears that this is extrapolation from the FISH staining of chr. 7, 12 and 18 on interphase nuclei. Identification of four signals per chromosome does not provide sufficient evidence of tetraploidy.

4\) How many cells from the population are really trisomic? In the original publication ([@bib69], Cancer Research), it was shown that only approximately 60 % of the cells DLD1 + 13 contain three copies of chromosome 13 (20% disomic, rest tetrasomic). In particular in the light of the main finding of the manuscript that aneuploidy facilitates further chromosomal instability it would be very useful to know the true karyotypic variability of the analyzed cell lines (in particular when specifically the trisomic chromosome should be affected). The authors should at least provide percentage of trisomic cells within the population and show for example by multicolor FISH or by SNP arrays that no other recurrent aneuploidy occurred during the passaging. Also, providing the passage number would be useful. In the Materials and methods it is described that three cases of constitutional trisomy 13 and three diploid controls were used in the study. Is the result presented in figures as AF and AF+13 an average of these three different cell populations, or is it one example?

5\) The overexpression levels of protein Spartin should be quantified from three independent experiments. Further investigation into the importance of Spartin overexpression on cytokinesis failure is important as [Figure 4D](#fig4){ref-type="fig"} demonstrates that Spartin is substantially over-expressed in DLD+13. Thus, Spartin may be upregulated in part as a general consequence of aneuploidy, and not simply because of its increased copy number. Alternatively, is the region 13q.13.3 amplified in DLD1+13?

6\) The link to spastin, although intriguing, is not sufficiently substantiated to explain the observed phenotypes. How does the spartin/spastin pathway explain the increased rates of chromosome missegregation? An experiment showing that the overexpression of SPG20 in DLD1 leads to loss of spastin in midbody would be useful.

In addition to these points the referees suggested that some clarification of the text will be required to address some issues as follows:

The authors\' conclude that aneuploidy induces CIN. However, the cytokinesis block experiments in [Figures 3B and 3C](#fig3){ref-type="fig"} actually argue against this statement. The authors report that only 1 out of 11 euploid chromosomes display frequent missegregation, while 3 out of 3 aneuploid chromosomes display frequent missegregation. This suggests that aneuploidy does not induce a general state of CIN, but instead aneuploid cells have particular trouble segregating aneuploid chromosomes. This discovery is certainly very interesting and worthy of further exploration. However, it undercuts the conclusion that aneuploidy causes CIN.

The authors claim that: "...addition to previously described mechanisms, \[these findings\] might explain the significantly higher rates of anaphase..." (in the Discussion). This implies that they found a new mechanism. However, no new mechanism of chromosome segregation errors is proposed, in particular if they state that there are no multipolar mitoses.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled "Aneuploidy causes chromosome mis-segregation and karyotype-dependent phenotypes in human cells" for further consideration at *eLife*. Your revised article has been favorably evaluated by Stylianos Antonarakis (Senior editor), a member of the Board of Reviewing Editors, and two reviewers. Both referees agree that the manuscript has been significantly improved but one reviewer is concerned by the generality of the conclusions that you can draw from your study. Thus, in your final, revised manuscript it will be necessary to tone down your conclusions and mention the caveats that the reviewer identifies.

*Reviewer \#2*:

The authors addressed a majority of the main concerns and the manuscript has significantly improved. However, there remain some issues that are difficult to reconcile and that at this point prevent me from recommendation for publication:

1\) Somehow it is difficult to accept the general conclusion---"Aneuploidy causes chromosome mis-segregation"---when it is made on the basis of analysis of two different trisomies in only one cancerous and p53 deficient cell line (AF cells only with trisomy 13 were analyzed). Thus, this sweeping conclusion with potentially large consequences for the field of aneuploidy and cancer biology is based on comparison of two different trisomies. By the way, the authors have AF cells with trisomy of chromosome 18 and 21, but do not provide any data on the missegregation there. They only use them to show the levels of spartin and other proteins ([Figure 4](#fig4){ref-type="fig"}).

2\) By FISH the authors observe missegregation basically only of chromosome 7 and/or 13, however, the chromosome count clearly show that there must be more chromosome missegregated. The authors just hand wave this. Moreover, chromosome 7 is not missegregated in AF+13, although it is frequently affect in DLD1+13. Why is that? Could the cell type of DLD1, colorectal cancer, affect the results, since the copy numbers of chromosome 7 and 13 are frequently altered in colorectal cancers?
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Author response

*While both referees found your results interesting, they raised several concerns that are set out below. One referee commented that your mechanistic analysis of Spartin is interesting but based on two evidentiary leaps. First, that transient transfection of Spartin mimics the trisomic state, and second, that knockdown of Spartin mimics the disomic state. They suggested that you could strengthen this evidence using more specific techniques (lentiviral infection to introduce one copy of Spartin into the genome; CRISPR to remove one allele). These would undoubtedly strengthen your case but are substantial undertakings; therefore, in revising your study you should characterise your Spartin over expression and knock-down cell lines more carefully and discuss the potential caveats of your approaches*.

Although we realize that different experimental approaches have different strengths and weaknesses, we would like to point out here that we have now performed experiments to better characterize the role of Spartin in cytokinesis failure in trisomy 13 amniocytes (AF+13). By WB quantification, we find Spartin expression in AF+13 cells to be ∼1.5-fold that observed in AF cells, indicating that this system is much more comparable to the addition of a single copy of the gene. Our experiments in AF+13 cells fully support our previous findings in DLD1+13 cells.

*Major points*:

*1) The findings described here are at odds with the findings by* [@bib72]*. This study reported minimal chromosomal instability among aneuploid cells with eight different karyotypes. Only two different karyotypes are examined in this paper. This raises the question of the extent to which these results can be generalised*.

We have now included a more exhaustive discussion (in the subsection headed "Chromosomal instability in trisomic cells") of our Results in light of the study by [@bib72]. Briefly, we would like to summarize here a few points: (i) Valind et al. found an increase of (CIN)/somatic mosaicism for certain chromosomes in cells with certain karyotypes, and this information can be found in a supplemental table of the paper. Yet, the chromosomal instability they observed does not match that observed in CIN cancer cells (which is also the case in our study). However, this should not be surprising as the degree of CIN may scale up with the degree of aneuploidy. (ii) The cell type used in the Valind et al. study may also partly explain the difference between their data and other studies, such as studies using peripheral blood lymphocytes of Turner and Down syndrome patients ([@bib49]; [@bib50]). (iii) Although Valind et al. analyzed more karyotypes, we examined more chromosomes and used several different approaches, as opposed to the single experimental approach used by Valind et al. We believe that a major reason for the discrepant conclusions reached by studies published over the years may be the difference in approaches used to assess CIN. When looking at cells undergoing mitosis (as we did in this study), one can directly assess the mis-segregation rates. However, mis-segregating cells may or may not divide further. Cell types in which mis-segregation does not cause a cell cycle arrest will "amplify" the aneuploidy by producing aneuploid daughter cells that will, in turn, keep dividing. In this case, using interphase FISH would be good enough to determine that aneuploidy promotes chromosome mis-segregation. However, if the cells produced after a mis-segregation event stop dividing, interphase FISH will largely underestimate the ability of aneuploidy to promote chromosome mis-segregation. In more extreme cases, mis-segregation could even result in cell death, and this again would result in very low levels of CIN as measured by interphase FISH even in the presence of high rates of chromosome mis- segregation. Thus, cell type-specific differences in aneuploidy-induced cell cycle arrest or cell death may explain the discrepancies between different studies. We believe that one strength of our study is the use of several different approaches to investigate the role of aneuploidy in causing chromosome mis-segregation and karyotipic heterogeneity/CIN. The points summarized here are now extensively discussed in the manuscript (please see the Discussion section).

*2) Two phenotypes of aneuploid cells are described in this manuscript: cytokinesis failure and the generation of lagging chromosomes. Are these two phenotypes related or distinct? Tetraploid cells are known to be chromosomally-unstable (e.g., Fujiwara, 2005). Are the lagging chromosomes in* [*Figure 2*](#fig2){ref-type="fig"} *occurring specifically in tetraploid cells? This could be tested by sorting a 2N population from each cell line and looking for laggards. FiFISH staining of chr. 7, 12 and 18 on interphase nuclei. How often are multipolar mitoses (which would be expected with the high frequency of tetraploidy) observed*?

Whereas it has been previously shown that tetraploid cells display high degrees of CIN ([@bib14]; [@bib21]), and that multipolarity promotes formation of merotelic kinetochore attachments and hence anaphase lagging chromosomes ([@bib22]; [@bib61]), we think that the two phenotypes we observe in our study are independent of each other. We believe this to be the case for two reasons: first, we do not observe multipolar mitoses (data now added in [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}); second, we find increased rates of anaphase lagging chromosomes also in DLD1+7, where tetraploidy is rare. We realize that the lack of multipolar mitoses in DLD1+13, where a significant fraction of the population is tetraploid may be surprising, as it was to us. However, this is in agreement with unpublished data from our lab in which we found normal centrosome numbers (1 centrosome/2 centrioles in G1, 2 centrosomes/2 centriole pairs in mitosis) in tetraploid cell clones generated by experimentally inhibiting cytokinesis. We now present the data on multipolar mitoses in the Results (in the subsection headed "Increased chromosome mis-segregation in cells with trisomy 7 or 13"; [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}) and discuss the points summarized here in the Discussion section.

*3) How was the tetraploidy/near tetraploidy determined? In* [*Figure 3D*](#fig3){ref-type="fig"}*, there appear to be more tetraploid wild-type AF cells than tetraploid AF +13 cells. However, in* [*Figure 3F*](#fig3){ref-type="fig"}*, the opposite is shown.* [*Figure 3F*](#fig3){ref-type="fig"} *shows that at least 5 % of AF+13 cells are tetraploid/near tetraploid without explaining how were these number obtained. In the text it appears that this is extrapolation from the FISH staining of chr. 7, 12 and 18 on interphase nuclei. Identification of four signals per chromosome does not provide sufficient evidence of tetraploidy*.

We realize that this point was not well explained in the previous version of the manuscript. We have now clarified (mainly in the figure legend) that, as the reviewers pointed out, the data in [Figure 3F](#fig3){ref-type="fig"} are a quantification of interphase FISH with probes specific for three different chromosomes. The reviewers are also correct in that chromosome counts did not reveal tetraploidy in AF+13. However, as we now explain in the text (in the subsections "Increased chromosome mis-segregation in cells with trisomy 7 or 13" and "Aneuploidy confers karyotype-dependent phenotypes"), this could easily be explained if tetraploid AF+13 cells became arrested in the cell cycle. If this were the case, then one would expect to see tetraploid chromosome numbers in interphase nuclei, but not in metaphase spreads. We believe that simultaneous detection of four signals per chromosome for three different chromosomes constitutes strong evidence of tetraploidy in AF+13 nuclei.

*4) How many cells from the population are really trisomic? In the original publication (*[@bib69]*, Cancer Research), it was shown that only approximately 60 % of the cells DLD1 + 13 contain three copies of chromosome 13 (20% disomic, rest tetrasomic). In particular in the light of the main finding of the manuscript that aneuploidy facilitates further chromosomal instability it would be very useful to know the true karyotypic variability of the analyzed cell lines (in particular when specifically the trisomic chromosome should be affected). The authors should at least provide percentage of trisomic cells within the population and show for example by multicolor FISH or by SNP arrays that no other recurrent aneuploidy occurred during the passaging. Also, providing the passage number would be useful. In the Materials and methods it is described that three cases of constitutional trisomy 13 and three diploid controls were used in the study. Is the result presented in figures as AF and AF+13 an average of these three different cell populations, or is it one example*?

The reviewers are correct. But because of the tendency of DLD1+13 cells to lose one copy of chromosome 13, the cells were subcloned at the beginning of this study. The cell population used for this study was assessed by chromosome painting with a FISH probe specific for chromosome 13 and we found that 83.5% of the cells were trisomic, 2.5% were tetraploid, and 4% were diploid. These data are now included in [Figure 1](#fig1){ref-type="fig"}. Moreover, aCGH data collected at later passages indicated no recurrent aneuploidy, although at that point the trisomic cell population had already diminished, as expected also based on our chromosome count data ([Figure 3D](#fig3){ref-type="fig"}). A thorough description of this characterization of DLD1+13 cells, as well as characterization of AF+13 cells and specific information of the passage number at which various experiments were performed are now provided in the Results section, [Figure 1](#fig1){ref-type="fig"}, and [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}).

Moreover, we have now included information on AF cells in [Table 1](#tbl1){ref-type="table"}. The results presented for AF and AF+13 are in all cases averages of the three different cell populations listed in [Table 1](#tbl1){ref-type="table"}.

*5) The overexpression levels of protein Spartin should be quantified from three independent experiments. Further investigation into the importance of Spartin overexpression on cytokinesis failure is important as* [*Figure 4D*](#fig4){ref-type="fig"} *demonstrates that Spartin is substantially over-expressed in DLD+13. Thus, Spartin may be upregulated in part as a general consequence of aneuploidy, and not simply because of its increased copy number. Alternatively, is the region 13q.13.3 amplified in DLD1+13*?

We have now included quantification of western blot data from three independent experiments (DLDs) or samples (AFs) ([Figure 4E-F](#fig4){ref-type="fig"}). The amount of Spartin in DLD1+7 argues against a possible overexpression of Spartin as a general consequence of aneuploidy. Moreover, we also found that Spartin was not overexpressed in amniocytes carrying other trisomies (data now shown in Figure 4--figure supplement 5). Finally, the aCGH data ([Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}) shows no evidence of amplification of region 13q13.3.

*6) The link to spastin, although intriguing, is not sufficiently substantiated to explain the observed phenotypes. How does the spartin/spastin pathway explain the increased rates of chromosome missegregation? An experiment showing that the overexpression of SPG20 in DLD1 leads to loss of spastin in midbody would be useful*.

It is possible that this was not clearly explained in the previous version of the manuscript, but we are not suggesting that the two different phenotypes described here (anaphase lagging chromosomes and cytokinesis failure) are both induced by mis- regulation of the spartin/spastin pathway. In fact, high rates of anaphase lagging chromosomes were also observed in DLD1+7 cells, which did not display spartin overexpression. We have revised the text throughout and we think it is now clear that, based on our data, we conclude that aneuploidy, regardless of the identity of the aneuploid chromosome, can promote chromosome mis-segregation. Our second conclusion is that different aneuploidies confer different phenotypes. In our study, we identified one such karyotype-phenotype connection by identifying a link between trisomy 13 and cytokinesis failure. To better get this point across, we have also slightly changed the title of the manuscript from "Aneuploidy causes karyotype-dependent phenotypes in human cells" to "Aneuploidy causes chromosome mis-segregation and karyotype-dependent phenotypes in human cells." Finally, we think that the experiment suggested by the reviewers would have been a nice addition to our study, and therefore we attempted it. However, the low efficiency of transfection combined with the low number of cells in cytokinesis undermined the success of this experiment.

*In addition to these points the referees suggested that some clarification of the text will be required to address some issues as follows*:

*The authors\' conclude that aneuploidy induces CIN. However, the cytokinesis block experiments in* [*Figures 3B and 3C*](#fig3){ref-type="fig"} *actually argue against this statement. The authors report that only 1 out of 11 euploid chromosomes display frequent missegregation, while 3 out of 3 aneuploid chromosomes display frequent missegregation. This suggests that aneuploidy does not induce a general state of CIN, but instead aneuploid cells have particular trouble segregating aneuploid chromosomes. This discovery is certainly very interesting and worthy of further exploration. However, it undercuts the conclusion that aneuploidy causes CIN*.

We now discuss our data more extensively (in the subsection entitled "Increased chromosome mis-segregation in cells with trisomy 7 or 13") and point out that although our cytokinesis-block assay ([Figure 3B-C](#fig3){ref-type="fig"}) showed chromosome mis- segregation to be limited to certain chromosomes, the chromosome count data ([Figure 3D](#fig3){ref-type="fig"}) suggest that chromosome mis-segregation must be more widespread than the cytokinesis-block assay reveals. For instance, the karyotypic heterogeneity observed in DLD1+7 cells, with chromosome numbers ranging between 42 and 53 ([Figure 3D](#fig3){ref-type="fig"}), cannot be explained by exclusive mis-segregation of chromosome 7 ([Figure 3B](#fig3){ref-type="fig"}), because this would produce a narrower chromosome number distribution around the modal number of 47.

*The authors claim that:* "*...addition to previously described mechanisms, \[these findings\] might explain the significantly higher rates of anaphase...*" *(in the Discussion). This implies that they found a new mechanism. However, no new mechanism of chromosome segregation errors is proposed, in particular if they state that there are no multipolar mitoses*.

The reviewers are correct that the wording used in our Discussion was inaccurate. The Discussion has been extensively revised and this statement no longer appears in the text.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*1) Somehow it is difficult to accept the general conclusion---*"*Aneuploidy causes chromosome mis-segregation*"*---when it is made on the basis of analysis of two different trisomies in only one cancerous and p53 deficient cell line (AF cells only with trisomy 13 were analyzed). Thus, this sweeping conclusion with potentially large consequences for the field of aneuploidy and cancer biology is based on comparison of two different trisomies. By the way, the authors have AF cells with trisomy of chromosome 18 and 21, but do not provide any data on the missegregation there. They only use them to show the levels of spartin and other proteins (*[*Figure 4*](#fig4){ref-type="fig"}*)*.

We have addressed this concern by making a number of changes, starting with the title, which now reads: "Chromosome mis-segregation and cytokinesis failure in trisomic human cells." We also toned down our Discussion by specifying that the conclusion on chromosome mis-segregation is limited to the trisomies studied here (see first line of the Discussion). We also acknowledged the caveats related to the limited number of trisomies and limited number of chromosomes analyzed in our FISH experiments (see end of the subsection headed "Increased chromosome mis-segregation in cells with trisomy 7 or 13"). We finally acknowledged that "certain aneuploidies may not be sufficient to induce chromosome mis-segregation" (please see "Chromosomal instability in trisomic cells").

*By the way, the authors have AF cells with trisomy of chromosome 18 and 21, but do not provide any data on the missegregation there. They only use them to show the levels of spartin and other proteins (*[*Figure 4*](#fig4){ref-type="fig"}*)*.

Although we have access to AF cells with other trisomies, we would like to point out that the experiments we performed (including several based on live-cell imaging) are technically very challenging in amniocytes. This may explain why other studies investigating the link between aneuploidy and CIN in primary cells employ interphase FISH as the only method of analysis. We feel that by using multiple approaches we can gain a deeper knowledge. However, analyzing other trisomies at this stage may delay the publication of this work by one or two years. Although we agree that it will be interesting to study these other trisomies and plan to do so, we feel the work included in this manuscript constitutes a complete story and its publication should not be delayed further.

*2) By FISH the authors observe missegregation basically only of chromosome 7 and/or 13, however, the chromosome count clearly show that there must be more chromosome missegregated. The authors just hand wave this*.

We feel that we did not hand wave this point, as we had discussed this both in the Results section and in the Discussion. However, we realize that discussing this point in two different places may have caused it to blend in the text and not stand out. So, we removed the discussion from the Results section and expanded our discussion of this issue in the Discussion section.

*Moreover, chromosome 7 is not missegregated in AF+13, although it is frequently affect in DLD1+13. Why is that? Could the cell type of DLD1, colorectal cancer, affect the results, since the copy numbers of chromosome 7 and 13 are frequently altered in colorectal cancers*?

We discuss now the distinct chromosome 7 mis-segregation rates found in DLD1+13 and AF+13 as suggested by the reviewer (please see the Discussion: "On the other hand, the finding that chromosome 7 mis-segregated in DLD1+13 \[...\]a cell type-specific effect is plausible").

[^1]: Cell and Tissue Biology, School of Dentistry, University of California, San Francisco, San Francisco, United States.

[^2]: Gastrointestinal and Pancreatic Oncology Group, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut D\'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
